Blood-Based Biomarker for Parkinson’s Disease Market

The blood-based biomarker for Parkinson's disease market consists of molecular indicators found in blood that provide insights into the disease's presence, progression, and treatment response. Key customers include hospitals, diagnostic laboratories, research institutes, and pharmaceutical companies. Growth is driven by the increasing demand for minimally invasive diagnostics for early-stage detection, rising clinician awareness, and the integration of advanced multi-omics technologies for biomarker discovery and validation.